BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wooldridge LM, Ji L, Liu Y, Nikas SP, Makriyannis A, Bergman J, Kangas BD. Antiemetic Effects of Cannabinoid Agonists in Nonhuman Primates. J Pharmacol Exp Ther 2020;374:462-8. [PMID: 32561684 DOI: 10.1124/jpet.120.265710] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kangas BD. Examining the effects of psychoactive drugs on complex behavioral processes in laboratory animals. Behavioral Pharmacology of Drug Abuse: Current Status 2022. [DOI: 10.1016/bs.apha.2021.09.001] [Reference Citation Analysis]
2 Wilkerson JL, Bilbrey JA, Felix JS, Makriyannis A, McMahon LR. Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline? Pharmacol Biochem Behav 2021;206:173192. [PMID: 33932409 DOI: 10.1016/j.pbb.2021.173192] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Withey SL, Kangas BD, Charles S, Gumbert AB, Eisold JE, George SR, Bergman J, Madras BK. Effects of daily Δ9-Tetrahydrocannabinol (THC) alone or combined with cannabidiol (CBD) on cognition-based behavior and activity in adolescent nonhuman primates. Drug Alcohol Depend 2021;221:108629. [PMID: 33640678 DOI: 10.1016/j.drugalcdep.2021.108629] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]